What is the relationship between ADHD and non-suicidal self-injury? This research update teases out an understanding of these and other common co-morbidities in a manner that suggests a practical approach to dealing with both problems in our child and adolescent patients.

The health benefits of light therapy are expanding its use beyond winter depression. Here we explore those promises and pitfalls, including ADHD, PTSD, bipolar depression, binge eating, sleep disorders, dementia, sexual dysfunction, traumatic brain injury, diabetes, and arthritis.

Most patients with bipolar disorder have cognitive complaints, but it’s a mistake to diagnose them all with ADHD, and a mistake to miss the genuine ADHD-bipolar comorbidity as well. Inside, a step-by-step guide to teasing apart the diagnoses.

From ADHD to off-label uses, we detail how to dose atomoxetine, how pharmacogenomic testing affects it, and how it compares with stimulants and the other antidepressant for ADHD, viloxazine (Qelbree).

We all need to become more aware of the differences in the population prevalence of mental health problems among various communities. This research update offers more recent data, upending what we knew when DSM-5 came out, and giving us a better sense of how to assess black youth and avoiding bias in the diagnostic process.

The MTA was a classic research effort aimed at reaching more definitive conclusions about the relative effectiveness of stimulant medications and behavioral treatments for children and adolescents with Attention Deficit Hyperactivity Disorder (ADHD). The results have proven enduring and inspiring, leading to the development of new and innovative treatment approaches.

Now that guanfacine ER (Intuniv) and clonidine ER (Kapvay) have gone generic, we review the 40-years of research that earned them FDA approval in ADHD. Along the way we’ll consider their off-label use in anxiety, addiction, insomnia, and self-harm. Plus: When to use the ER, the instant release, or the oft-forgotten transdermal patch.

Does ADHD bring creative strengths? Can stimulants dampen creative thought? New research suggests they can, but the effect varies by patient.

There are many fairly benign interventions that are tried in child and adolescent mental health, and a large number are specifically aimed at treating Attention Deficit Hyperactivity Disorder (ADHD). One such treatment is the use of vitamin D. But is it helpful, and if so, what dosages are safe to use? This article uses current research to address these questions.

Children and adults respond differently to medications for ADHD. This first-of-its-kind trial tested out the pediatric-approved guanfacine ER (Intuniv) in adult ADHD.